Free Newsletter

The Daily Briefing

Cannabis industry intelligence for people who take the industry seriously. Delivered free every weekday morning.

Industry data, company analysis, and investment insights you won't find elsewhere.

Legislation updates across all 50 states. Know what's changing before it changes.

Peer-reviewed cannabis research translated into language that matters.

Data-driven strain profiles with terpene analysis and community ratings.

Sample Briefing

DEA signals rescheduling timeline

The agency confirmed it will publish a final rule on cannabis rescheduling by Q3, moving marijuana from Schedule I to Schedule III...

Curaleaf reports 12% YoY revenue growth

The MSO posted $340M in Q4 revenue, driven by New Jersey adult-use sales and international expansion...

Study: CBG shows promise for neuroinflammation

Researchers at UF found that cannabigerol reduced inflammatory markers in mouse models of neurodegeneration...

60 seconds to read · Delivered every weekday

"The only cannabis newsletter I actually read every day."

— You, probably, after the first week